MOH — authorised 18 October 2013
- Marketing authorisation holder: ACTELION PHARMS LTD
- Status: likely_approved
MOH authorised Opsumit on 18 October 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 18 October 2013.
ACTELION PHARMS LTD holds the Israeli marketing authorisation.